Electra Therapeutics, Inc.

Healthcare · Biotechnology · United States

Last price 8.1 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 508.41M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Electra Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The company develops therapies that targets signal regulatory proteins for the treatment of novel targets for treatment of immune-mediated diseases and cancer. Its lead product candidate is ipsoprubart, that targets signal regulatory protein on the cell surface of myeloid and T cells and depletes pathological immune cells, treatment for secondary hemophagocytic lymphohistiocytosis and T/NK Cell Malignancies; ELA822, a novel SIRP-specific monoclonal antibody for deplete ac...